Urinary endothelin-1 as a marker of renal damage in sickle cell disease

Nephrology Dialysis Transplantation

Volumn 20, Issue 11, 2005, Pages 2408-2413

  Tharaux, Pierre Louis ^a   Hagège, Isabelle ^a   Placier, Sandrine ^a   Vayssairat, Michel ^a   Kanfer, Alain ^a   Girot, Robert ^a   Dussaule, Jean Claude ^a,b  

^a HÔPITAL TENON   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

Endothelin 1; Hypoxia; Nephrogenic diabetes insipidus; Sickle cell disease

Indexed keywords

DESMOPRESSIN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; VASOPRESSIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEHYDRATION; DISEASE MARKER; FEMALE; HORMONE INHIBITION; HUMAN; KIDNEY CONCENTRATING CAPACITY; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY SCAR; KIDNEY TUBULE FUNCTION; MALE; NEGRO; NEPHROGENIC DIABETES INSIPIDUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN URINE LEVEL; SICKLE CELL ANEMIA; URINARY EXCRETION; WATER DEPRIVATION;

ADULT; ALBUMINURIA; ANEMIA, SICKLE CELL; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIABETES INSIPIDUS, NEPHROGENIC; DISEASE PROGRESSION; ENDOTHELIN-1; FEMALE; HUMANS; KIDNEY TUBULES; MALE; RADIOIMMUNOASSAY; SEVERITY OF ILLNESS INDEX;

EID: 27644485935     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi111     Document Type: Article

References (20)

1. Brezis ML, Rosen S. Hypoxia of the renal medulla - its implications for disease. N Engl J Med 1995; 332: 647-655
2. Lesobre B, Pieron R, Mafart Y, Paillard F, Coudray J, Boulu P. Défaut de concentration urinaire dans la drépanocytose et l'hémoglobinopathie S-C. Ann Med Interne 1978; 129: 289-292
3. Falk RJ, Sheinman J, Phillips G, Orringer E, Johnson A, Jennette JC. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med 1992; 326: 910-915
4. Firth J, Ratcliffe J. Organ distribution of the three rat endothelin messengers RNAs and the effects of ischaemia on renal gene expression. J Clin Invest 1992; 90: 1023-1031
5. Phelan M, Perrine SP, Brauer M, Faller DV. Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture. J Clin Invest 1995; 96: 1145-1151
6. Miller RL and Kohan DE. Hypoxia regulates endothelin-1 production by the inner medullary collecting duct. J Lab Clin Med 1998; 131: 45-48
7. Rybicki AC, Benjamin LJ. Increased levels of endothelin-1 in plasma of sickle cell anemia patients. Blood 1998; 92: 2594-2596
8. Werdehoff SG, Moore RB, Hoff CJ, Fillingim E, Hackman AM. Elevated plasma endothelin-1 levels in sickle cell anemia: Relationships to oxygen saturation and left ventricular hypertrophy. Am J Hematol 1998; 58: 195-199
9. Graido-Gonzalez E, Doherty JC, Bergreen EW, Organ G, Telfer M, McMillen MA. Plasma Endothelin-1, Cytokine, and Prostaglandin E2 Levels in Sickle Cell Disease and Acute Vaso-Occlusive Sickle Crisis. Blood 1998; 92: 2551-2555
10. Janas J, Sitkiewicz D, Januszewicz A, Szczesniak C, Grenda R, Janas RM. Endothelin-1 inactivating peptidase in the human kidney and urine. J Hypertens 2000; 18: 475-483
11. Oishi R, Nonoguchi H, Tomita K, Marumo F. Endothelin-1 inhibits AVP-stimulated osmotic water permeability in rat inner medullary collecting duct. Am J Physiol 1991; 261: F951-F956
12. Nadler SP, Zimpelmann JA, Hebert RL. Endothelin inhibits vasopressin-stimulated water permeability in rat terminal inner medullary collecting duct. J Clin Invest 1992; 90: 1458-1466
13. Neonato MG, Guilloud-Bataille M, Beauvais P et al. Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease. Eur J Haematol 2000; 65: 155-164
14. Evans RR, Phillips BG, Singh G, Bauman JL, Gulati A. Racial and gender differences in endothelin-1. Am J Cardiol 1996; 78: 486-488
15. Treiber FA, Jackson RW, Davis H et al. Racial differences in endothelin-1 at rest and in response to acute stress in adolescent males. Hypertension 2000; 35: 722-725
16. Ferri C, Bellini C, Desideri G et al. Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes 1995; 44: 431-436
17. Orth SR, Schomig M, Ritz E. Pharmacological intervention in progressive renal diseases. Nephrol Dial Transplant 2001; 16 [Suppl 5]: 19-25
18. Kohan DE, Padilla E. Osmolar regulation of endothelin-1 production by rat inner medullary collecting duct. J Clin Invest 1993; 91: 1235-1240
19. Zoja C, Morigi M, Figliuzzi M et al. Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis 1995; 26: 934-941
20. Rivera A, Rotter MA, Brugnara C. Endothelins activate Ca21-gated K1 channels via endothelin B receptors in CD-1 mouse erythrocytes. Am J Physiol 1999; 277: C746-C754